AGENUS INC Amortization of Intangible Assets
AGENUS INC (AGEN) reported Amortization of Intangible Assets of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-16
- AGENUS INC amortization of intangible assets for fiscal 2025 was $300.00K, a 40.00% decline from fiscal 2024.
- AGENUS INC amortization of intangible assets for fiscal 2024 was $500.00K, a 66.67% decline from fiscal 2023.
- AGENUS INC amortization of intangible assets for fiscal 2023 was $1.50M, a 31.82% decline from fiscal 2022.
- AGENUS INC amortization of intangible assets for fiscal 2022 was $2.20M, a 4.76% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-03-16 | |
| 2024-12-31 | $500.00K 10-K · filed 2026-03-16 | |
| 2023-12-31 | $1.50M 10-K · filed 2026-03-16 | |
| 2022-12-31 | $2.20M 10-K · filed 2025-03-17 | |
| 2021-12-31 | $2.10M 10-K · filed 2024-03-14 | |
| 2020-12-31 | $2.40M 10-K · filed 2023-03-16 | |
| 2019-12-31 | $2.00M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $2.00M 10-K · filed 2021-03-16 | |
| 2017-12-31 | $2.30M 10-K · filed 2020-03-16 | |
| 2016-12-31 | $2.20M 10-K · filed 2018-03-16 | |
| 2015-12-31 | $2.20M 10-K · filed 2019-03-18 | $525.00K 10-K · filed 2016-03-15 |
| 2014-12-31 | $462.00K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 | |
| 2010-12-31 | $690.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |